Ascentage Pharma Group International (AAPG) Retained Earnings (2023 - 2024)
Historic Retained Earnings for Ascentage Pharma Group International (AAPG) over the last 2 years, with Q4 2024 value amounting to -$803.4 million.
- Ascentage Pharma Group International's Retained Earnings fell 781.11% to -$803.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$803.4 million, marking a year-over-year decrease of 781.11%. This contributed to the annual value of -$790.6 million for FY2024, which is 413.42% down from last year.
- Per Ascentage Pharma Group International's latest filing, its Retained Earnings stood at -$803.4 million for Q4 2024, which was down 781.11% from -$745.1 million recorded in Q4 2023.
- In the past 5 years, Ascentage Pharma Group International's Retained Earnings registered a high of -$745.1 million during Q4 2023, and its lowest value of -$803.4 million during Q4 2024.